| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/31/2002 | US20020160403 huBUB3 gene involved in human cancers |
| 10/31/2002 | US20020160395 Detection of survivin in the biological fluids of cancer patients |
| 10/31/2002 | US20020160394 Regulation of transthyretin to treat obesity |
| 10/31/2002 | US20020160392 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/31/2002 | US20020160390 Polymorphic DNAs and their use for diagnosis of susceptibility to panic disorder |
| 10/31/2002 | US20020160388 Compositions and methods relating to lung specific genes and proteins |
| 10/31/2002 | US20020160387 Compositions and methods relating to ovary specific genes and proteins |
| 10/31/2002 | US20020160386 Methods of using transporter-like molecules to treat pain and pain-related disorders |
| 10/31/2002 | US20020160384 Polypeptides; binding to antibodies |
| 10/31/2002 | US20020160383 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 10/31/2002 | US20020160382 Detection cell differentiation gene expression |
| 10/31/2002 | US20020160379 Gapped 2' modified oligonucleotides |
| 10/31/2002 | US20020160378 Detection hybrids; cell differentiation; gene expression; |
| 10/31/2002 | US20020160377 In situ translation; generating fusion proteins; libraries |
| 10/31/2002 | US20020160375 Generating tissue; cell differentiation |
| 10/31/2002 | US20020160374 Fusion protein; genetic engineering; binding to antibodies |
| 10/31/2002 | US20020160372 Veterinary medicine; screening animal for litter size; polymerase chain reaction; amplification |
| 10/31/2002 | US20020160371 56739, a novel CUB domain containing protein and uses thereof |
| 10/31/2002 | US20020160365 Compositions and methods for the early diagnosis of ovarian cancer |
| 10/31/2002 | US20020160355 Methods and reagents for modulating TGF-beta superfamily signalling |
| 10/31/2002 | US20020160024 Modulating movement of a cell within or to the skin of a mammal by administering to mammal an effective amount of an antagonist an agonist of CTACK, an antagonist or agonist of Vic chemokines |
| 10/31/2002 | US20020160020 Enterohemorrhagic escherichia coli vaccine |
| 10/31/2002 | US20020160019 Providing peptide that bears a DR motif corresponding to a Class II HLA molecule, testing peptide for binding affinity to a Class II HLA DR molecule, whereupon an IC50 binding affinity is determined |
| 10/31/2002 | US20020160018 For inducing in a bovine host an immunological response against bovine respiratory syncytial virus or bovine viral diarrhea virus |
| 10/31/2002 | US20020160017 Malaria vaccine |
| 10/31/2002 | US20020160016 Modified surface antigen |
| 10/31/2002 | US20020160015 Chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes and its uses |
| 10/31/2002 | US20020160014 Cancer immunotherapy, particularly with immunotherapeutic combinations and treatment methods to prevent tumor cell growth and/or to eliminate those cells |
| 10/31/2002 | US20020160013 Used in diagnosis and therapy of diseases that involve inadequate or inappropriate receptor response as well as in the screening of drug candidates that affect surface expression of receptors |
| 10/31/2002 | US20020160012 Vaccine chip technology exploiting immunostimulating fragment of TGF-BETA |
| 10/31/2002 | US20020160009 For treatment of disseminated candidiasis due to infection by C. albicans; composition includes phosphomannan of C. albicans |
| 10/31/2002 | US20020160006 Methods of treating lymphoma and leukemia |
| 10/31/2002 | US20020160004 Antibodies against flt3-ligand |
| 10/31/2002 | US20020160002 SseCKS gene encodes a substrate of protein kinase C that functions as both a mitogenic regulator as well as a tumor suppressor |
| 10/31/2002 | US20020160000 PD-1, a receptor for B7-4, and uses therefor |
| 10/31/2002 | US20020159998 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 10/31/2002 | US20020159991 Modulation of Abeta levels by beta-secretase BACE2 |
| 10/31/2002 | US20020159989 Peptide that interacts with thrombospondin 2 and inhibits matrix metalloproteinase 9 (MMP-9) activity, useful for treating diseases, such as cancer and arthritis |
| 10/31/2002 | US20020159979 Adeno- associated virus inverted terminal repeats flanking DNA sequences encoding an immunodeficiency virus protein operably linked to a promoter and polyadenylation sequences |
| 10/31/2002 | US20020159977 Administering a recombinant adeno-associated virion into human suffering from hemophilia such that factor VIII nuclotide sequence are expressed at a level which provide therapeutically effective amount in the patient |
| 10/31/2002 | US20020159976 An isolated polynucleotide comprising a nucleotide sequence present in Lactobacillus rhamnosus strain HN001 that encodes a polypeptide having atleast one enzymetic activity; genetic engineering |
| 10/31/2002 | US20020159972 Nucleic acids encoding IL13 mutants |
| 10/31/2002 | US20020159970 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 10/31/2002 | US20020159969 A MUC-1 mucin (a high molecular weight glycoprotein) derivative, containing specific amino acid sequence and less than 60 amino acid in length, linked to a cytokine; clinically significant marker for cancers |
| 10/31/2002 | US20020159958 Methods for producing immunoglobulins containing protection proteins in plants and their use |
| 10/31/2002 | DE10121283A1 Verfahren und Vektoren zur Amplifikation oder Expression von gewünschten Nucleinsäuresequenzen in Pflanzen Methods and vectors for amplification or expression of the desired nucleic acid sequences in plants |
| 10/31/2002 | DE10118452A1 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Nucleic acid sequences of hyperplasias and tumors of the thyroid |
| 10/31/2002 | CA2807478A1 Use of follistatin to increase muscle mass |
| 10/31/2002 | CA2483507A1 Enzyme and snp marker for disease |
| 10/31/2002 | CA2445627A1 Methods of using a hyaluronan receptor |
| 10/31/2002 | CA2445258A1 Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides |
| 10/31/2002 | CA2445197A1 T1r3 a novel taste receptor |
| 10/31/2002 | CA2445179A1 Identification of essential genes of aspegillus fumigatus and methods of use |
| 10/31/2002 | CA2445171A1 A 150 kda tgf-beta 1 accessory receptor acting as a negative modulator of tgf-beta signaling |
| 10/31/2002 | CA2445011A1 Transformed silkworm producing human collagen |
| 10/31/2002 | CA2444709A1 Compositions and methods to control bleeding |
| 10/31/2002 | CA2444696A1 Polynucleotides and polypeptides associated with the nf-kb pathway |
| 10/31/2002 | CA2444691A1 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 10/31/2002 | CA2444683A1 Antimicrobial polypeptides and their uses |
| 10/31/2002 | CA2444680A1 Binding molecules for fc-region polypeptides |
| 10/31/2002 | CA2444675A1 Secreted proteins |
| 10/31/2002 | CA2444654A1 Molecular sequence of pig endogenous retrovirus receptors and methods of use |
| 10/31/2002 | CA2444617A1 Production of genetically modified plants with puroindolines |
| 10/31/2002 | CA2444602A1 Anti-obesity polypeptides |
| 10/31/2002 | CA2444594A1 Sprr1a and axonal regeneration |
| 10/31/2002 | CA2444235A1 New polynucleotides and polypeptides of the ifn.alpha.-17 gene |
| 10/31/2002 | CA2444195A1 Compositions and methods for recombinational cloning of nucleic acid molecules |
| 10/31/2002 | CA2444098A1 Methods and compositions for the production of orthogonal trna-aminoacyl trna synthetase pairs |
| 10/31/2002 | CA2444006A1 Expression of core-glycosylated hcv envelope proteins in yeast |
| 10/31/2002 | CA2443913A1 Interleukin-1 homolog zil1a7 |
| 10/31/2002 | CA2443781A1 Core-glycosylated hcv envelope proteins |
| 10/31/2002 | CA2443770A1 Proteins and nucleic acids encoding same |
| 10/31/2002 | CA2443757A1 In vivo incorporation of unnatural amino acids |
| 10/31/2002 | CA2443740A1 Constructs and methods for expression of recombinant hcv envelope proteins |
| 10/31/2002 | CA2443373A1 New polynucleotides and polypeptides of the erythropoietin gene |
| 10/31/2002 | CA2441540A1 Replikin peptides and uses thereof |
| 10/31/2002 | CA2439693A1 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof |
| 10/31/2002 | CA2439690A1 Modified interferon alpha with reduced immunogenicity |
| 10/31/2002 | CA2429351A1 A novel human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof |
| 10/30/2002 | EP1253201A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 10/30/2002 | EP1253200A1 Cocoa polypeptides and their use in the production of cocoa and chocolate flavour |
| 10/30/2002 | EP1253197A1 Attenuated recombinant rabies virus and live vaccines thereof |
| 10/30/2002 | EP1252337A2 Nucleic acids, proteins, and antibodies |
| 10/30/2002 | EP1252333A2 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 10/30/2002 | EP1252330A2 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy |
| 10/30/2002 | EP1252329A2 Hypocretin and hypocretin receptors in regulation of sleep and related disorders |
| 10/30/2002 | EP1252325A1 Compositions and methods for inhibition of hiv-1 infection |
| 10/30/2002 | EP1252319A2 Combinatorial protein domains |
| 10/30/2002 | EP1252315A2 Method for the production of a protein |
| 10/30/2002 | EP1252314A4 Identification and expression of human kir5.1 |
| 10/30/2002 | EP1252314A2 Identification and expression of human kir5.1 |
| 10/30/2002 | EP1252313A2 Use of dendroaspin as a vehicle for non-dendroaspin domains |
| 10/30/2002 | EP1252312A1 Nucleic acids, proteins, and antibodies |
| 10/30/2002 | EP1252311A2 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 10/30/2002 | EP1252310A2 Mlp gene, nucleic acids, polypeptides and the utilization thereof |
| 10/30/2002 | EP1252309A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 10/30/2002 | EP1252305A2 Full-length human cdnas encoding potentially secreted proteins |
| 10/30/2002 | EP1252303A2 Nucleic acids, proteins, and antibodies |
| 10/30/2002 | EP1252302A2 Nucleic acids, proteins, and antibodies |
| 10/30/2002 | EP1252297A1 Nucleic acids, proteins, and antibodies |